We are live on ! Find out more
Citadel Advisors

Citadel Advisors Portfolio holdings

AUM $618B
1-Year Est. Return 30.34%
 

Citadel Advisors, founded in 1990 by Kenneth C. Griffin as Citadel LLC and headquartered in Chicago, Illinois, is one of the world’s most prominent hedge funds, managing tens of billions in assets through sophisticated quantitative trading strategies. The firm excels in market-making and high-frequency trading across asset classes like equities, fixed income, options, and commodities, leveraging cutting-edge technology and data analysis to generate returns. Citadel operates two main arms: its hedge fund business, which serves institutional and high-net-worth investors, and Citadel Securities, a leading market maker that facilitates a significant portion of U.S. equity and options trades. Known for its secretive, high-performance culture, Citadel has grown into a financial titan under Griffin’s leadership, influencing global markets with its scale and innovation.

This Fund
S&P 500
This Quarter Est. Return
+3.28%
1 Year Est. Return
+30.34%
3 Year Est. Return
+94.87%
5 Year Est. Return
+105.94%
10 Year Est. Return
+434.06%
AUM
$118B
AUM Growth
+$8.59B
Cap. Flow
-$401M
Cap. Flow %
-0.34%
Top 10 Hldgs %
16.92%
Holding
8,702
New
1,333
Increased
3,126
Reduced
2,721
Closed
1,293

Top Buys

Rank Stock Value
1
AMAT icon
Applied Materials
AMAT
+$346M
2
AVGO icon
Broadcom
AVGO
+$326M
3
BA icon
Boeing
BA
+$263M
4
COF icon
Capital One
COF
+$258M
5
OXY icon
Occidental Petroleum
OXY
+$257M

Sector Composition

Rank Sector Weight
1 Technology 7.15%
2 Financials 5.56%
3 Consumer Discretionary 5.28%
4 Industrials 4.73%
5 Healthcare 4.45%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ADYX
7126
DELISTED
Adynxx Inc
ADYX
$20K ﹤0.01%
+900
New +$21.1K
KIQ
7127
DELISTED
Kelso Technologies Inc.
KIQ
$20K ﹤0.01%
24,324
-5,568
-19% -$4.27K
GCVRZ
7128
DELISTED
Sanofi Contingent Value Rights
GCVRZ
$20K ﹤0.01%
51,741
+6,941
+15% +$2.83K
ATNM icon
7129
CALL
Actinium Pharmaceuticals
ATNM
$25M
$19K ﹤0.01%
+513
New +$21.5K
INFU icon
7130
InfuSystem Holdings
INFU
$249M
$19K ﹤0.01%
+10,711
New +$19.3K
ASXC
7131
PUT
DELISTED
Asensus Surgical, Inc.
ASXC
$19K ﹤0.01%
2,054
-100
-5% -$951
WMGIZ
7132
DELISTED
Wright Medical Group, Inc. Contingent Value Right
WMGIZ
$19K ﹤0.01%
12,885
+508
+4% +$742
VVUS
7133
PUT
DELISTED
Vivus Inc
VVUS
$19K ﹤0.01%
1,560
-1,160
-43% -$12.7K
OGEN icon
7134
Oragenics
OGEN
$2.48M
$18K ﹤0.01%
3
+1
+50% +$7.41K
PFIE
7135
DELISTED
Profire Energy, Inc
PFIE
$18K ﹤0.01%
+14,097
New +$18.9K
KSPN
7136
DELISTED
Kaspien Holdings Inc. Common Stock
KSPN
$18K ﹤0.01%
+541
New +$18.9K
EVFM
7137
DELISTED
Evofem Biosciences, Inc. Common Stock
EVFM
$18K ﹤0.01%
363
+206
+131% +$36.1K
SMTX
7138
DELISTED
SMTC Corporation
SMTX
$18K ﹤0.01%
13,834
-1,350
-9% -$1.7K
ONCS
7139
DELISTED
OncoSec Medical Incorporated
ONCS
$18K ﹤0.01%
69
-53
-43% -$13K
MTSL
7140
DELISTED
MER TELEMANAGEMENT SOLUTNS LTD
MTSL
$18K ﹤0.01%
33,724
-8,996
-21% -$4.8K
ANY icon
7141
Sphere 3D
ANY
$16M
$17K ﹤0.01%
+6
New +$14.7K
CBAT icon
7142
CBAK Energy Technology Ltd
CBAT
$57.8M
$17K ﹤0.01%
+12,642
New +$17.4K
COHN icon
7143
Cohen & Co
COHN
$36.4M
$17K ﹤0.01%
1,435
-238
-14% -$2.83K
MARA icon
7144
Marathon Digital Holdings
MARA
$3.9B
$17K ﹤0.01%
+2,824
New +$19.8K
PPBT
7145
Purple Biotech
PPBT
$2.33M
$17K ﹤0.01%
6
+1
+20% +$3.64K
SINT icon
7146
SiNtx Technologies
SINT
$10.6M
0
TPST icon
7147
Tempest Therapeutics
TPST
$14.6M
$17K ﹤0.01%
4
VERU icon
7148
Veru
VERU
$37.4M
$17K ﹤0.01%
1,578
-93
-6% -$1K
XWEL icon
7149
CALL
XWELL
XWEL
$8.61M
$17K ﹤0.01%
+9
New +$18.8K
SEEL
7150
DELISTED
Seelos Therapeutics, Inc. Common Stock
SEEL
0

Similar funds

Citadel Advisors's Q2 2017 Portfolio in Review

As of Q2 2017, Citadel Advisors held 8,702 positions worth $118B, up 7.8% from $109B the previous quarter. Its ten largest holdings account for 17% of the portfolio.

Citadel Advisors's Q2 2017 filing shows 1,333 new, 3,126 increased, 2,721 reduced and 1,293 closed positions. Its largest new stake was Equity Residential: 2,436,064 shares worth $160M. The largest sale was Walt Disney, an estimated $550M.

By sector, the portfolio is most concentrated in Technology at 7.1% of assets, up from 7.1% a quarter earlier, followed by Financials and Consumer Discretionary.

  • Citadel Advisors's largest Q2 2017 buy was Equity Residential: 2,436,064 shares worth $160M.
  • Citadel Advisors added most to Applied Materials in Q2 2017, an estimated $346M increase.
  • Citadel Advisors's biggest Q2 2017 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $549M.
  • Citadel Advisors fully exited Walt Disney in Q2 2017, selling an estimated $550M.
  • Citadel Advisors's ten largest holdings make up 17% of its $118B portfolio in Q2 2017.
  • Citadel Advisors opened 1,333 new positions and closed 1,293 in Q2 2017.
  • Citadel Advisors's portfolio value rose 7.8% quarter-over-quarter to $118B.

Based on Citadel Advisors's 13F filing for Q2 2017, filed 11 Aug 2017.